Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular BioVector (SMBV)
- 10 January 1997
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1355 (1) , 7-19
- https://doi.org/10.1016/s0167-4889(96)00111-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Does antisense exist?Nature Medicine, 1995
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Transport of oligonucleotides across natural and model membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Problems in Interpretation of Data Derived fromin Vitroandin VivoUse of Antisense OligodeoxynucleotidesAntisense Research and Development, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system.Proceedings of the National Academy of Sciences, 1993
- Cell Delivery and Mechanisms of Action of Antisense OligonucleotidesPublished by Elsevier ,1993
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Specific regulation of gene expression by antisense, sense and antigene nucleic acidsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1990
- Antisense oligonucleotides: a new therapeutic principleChemical Reviews, 1990